AbbVie Inc.

JPMORGAN CHASE & CO ABBV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

52,393,323

Value ($000)

11,971,351

Weight

0.8%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	11,971,351	0.8%	52,393,323	12/31/2025
2025 Q3	11/7/2025	13,090,132	0.8%	56,534,816	9/30/2025
2025 Q2	8/12/2025	10,620,187	0.7%	57,214,407	6/30/2025
2025 Q1	5/12/2025	11,472,157	0.9%	54,754,470	3/31/2025
2024 Q4	2/12/2025	9,198,195	0.7%	51,762,491	12/31/2024
2024 Q3	11/8/2024	10,291,098	0.8%	52,112,101	9/30/2024
2024 Q2	8/12/2024	9,186,254	0.8%	53,557,915	6/30/2024
2024 Q1	5/10/2024	9,334,083	0.8%	51,258,003	3/31/2024
2023 Q4	2/12/2024	8,030,284	0.8%	51,818,311	12/31/2023
2023 Q3	11/14/2023	8,232,704	1.0%	55,230,808	9/30/2023
2023 Q2	8/11/2023	7,648,970	0.9%	56,772,580	6/30/2023
2023 Q1	5/18/2023	9,227,296	1.2%	57,898,564	3/31/2023
2022 Q4	2/13/2023	9,843,699	1.4%	60,910,214	12/31/2022
2022 Q3	11/14/2022	7,848,467	1.2%	58,479,009	9/30/2022
2022 Q2	8/11/2022	8,593,905	1.3%	56,110,635	6/30/2022
2022 Q1	5/11/2022	8,769,211	1.1%	54,094,198	3/31/2022
2021 Q4	2/11/2022	5,836,416	0.7%	43,104,988	12/31/2021
2021 Q3	11/12/2021	4,734,777	0.6%	43,893,358	9/30/2021
2021 Q2	8/12/2021	3,938,006	0.5%	34,960,994	6/30/2021
2021 Q1	5/12/2021	3,643,204	0.5%	33,664,795	3/31/2021
2020 Q4	2/19/2021	3,251,519	0.5%	30,345,495	12/31/2020
2020 Q3	11/12/2020	2,536,368	0.5%	29,190,573	9/30/2020
2020 Q2	8/11/2020	2,812,921	0.6%	28,650,659	6/30/2020
2020 Q1	5/12/2020	1,709,766	0.4%	22,440,791	3/31/2020
2019 Q4	2/11/2020	1,589,649	0.3%	17,954,007	12/31/2019
2014 Q1	5/15/2014	338,403	0.1%	6,583,713	3/31/2014
2013 Q4	2/26/2014	375,790	0.1%	7,115,907	12/31/2013